Cargando…
Presymptomatic transmission of SARS-CoV-2 infection: a secondary analysis using published data
OBJECTIVE: To estimate the proportion of presymptomatic transmission of SARS-CoV-2 infection that can occur, and the timing of transmission relative to symptom onset. SETTING/DESIGN: Secondary analysis of international published data. DATA SOURCES: Meta-analysis of COVID-19 incubation period and a r...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245290/ https://www.ncbi.nlm.nih.gov/pubmed/34183334 http://dx.doi.org/10.1136/bmjopen-2020-041240 |
_version_ | 1783716086785507328 |
---|---|
author | Casey-Bryars, Miriam Griffin, John McAloon, Conor Byrne, Andrew Madden, Jamie Mc Evoy, David Collins, Áine Hunt, Kevin Barber, Ann Butler, Francis Lane, Elizabeth Ann O'Brien, Kirsty Wall, Patrick Walsh, Kieran More, Simon John |
author_facet | Casey-Bryars, Miriam Griffin, John McAloon, Conor Byrne, Andrew Madden, Jamie Mc Evoy, David Collins, Áine Hunt, Kevin Barber, Ann Butler, Francis Lane, Elizabeth Ann O'Brien, Kirsty Wall, Patrick Walsh, Kieran More, Simon John |
author_sort | Casey-Bryars, Miriam |
collection | PubMed |
description | OBJECTIVE: To estimate the proportion of presymptomatic transmission of SARS-CoV-2 infection that can occur, and the timing of transmission relative to symptom onset. SETTING/DESIGN: Secondary analysis of international published data. DATA SOURCES: Meta-analysis of COVID-19 incubation period and a rapid review of serial interval and generation time, which are published separately. PARTICIPANTS: Data from China, the Islamic Republic of Iran, Italy, Republic of Korea, Singapore and Vietnam from December 2019 to May 2020. METHODS: Simulations were generated of incubation period and of serial interval or generation time. From these, transmission times relative to symptom onset, and the proportion of presymptomatic transmission, were estimated. OUTCOME MEASURES: Transmission time of SARS-CoV-2 relative to symptom onset and proportion of presymptomatic transmission. RESULTS: Based on 18 serial interval/generation time estimates from 15 papers, mean transmission time relative to symptom onset ranged from −2.6 (95% CI −3.0 to –2.1) days before infector symptom onset to 1.4 (95% CI 1.0 to 1.8) days after symptom onset. The proportion of presymptomatic transmission ranged from 45.9% (95% CI 42.9% to 49.0%) to 69.1% (95% CI 66.2% to 71.9%). CONCLUSIONS: There is substantial potential for presymptomatic transmission of SARS-CoV-2 across a range of different contexts. This highlights the need for rapid case detection, contact tracing and quarantine. The transmission patterns that we report reflect the combination of biological infectiousness and transmission opportunities which vary according to context. |
format | Online Article Text |
id | pubmed-8245290 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-82452902021-07-01 Presymptomatic transmission of SARS-CoV-2 infection: a secondary analysis using published data Casey-Bryars, Miriam Griffin, John McAloon, Conor Byrne, Andrew Madden, Jamie Mc Evoy, David Collins, Áine Hunt, Kevin Barber, Ann Butler, Francis Lane, Elizabeth Ann O'Brien, Kirsty Wall, Patrick Walsh, Kieran More, Simon John BMJ Open Epidemiology OBJECTIVE: To estimate the proportion of presymptomatic transmission of SARS-CoV-2 infection that can occur, and the timing of transmission relative to symptom onset. SETTING/DESIGN: Secondary analysis of international published data. DATA SOURCES: Meta-analysis of COVID-19 incubation period and a rapid review of serial interval and generation time, which are published separately. PARTICIPANTS: Data from China, the Islamic Republic of Iran, Italy, Republic of Korea, Singapore and Vietnam from December 2019 to May 2020. METHODS: Simulations were generated of incubation period and of serial interval or generation time. From these, transmission times relative to symptom onset, and the proportion of presymptomatic transmission, were estimated. OUTCOME MEASURES: Transmission time of SARS-CoV-2 relative to symptom onset and proportion of presymptomatic transmission. RESULTS: Based on 18 serial interval/generation time estimates from 15 papers, mean transmission time relative to symptom onset ranged from −2.6 (95% CI −3.0 to –2.1) days before infector symptom onset to 1.4 (95% CI 1.0 to 1.8) days after symptom onset. The proportion of presymptomatic transmission ranged from 45.9% (95% CI 42.9% to 49.0%) to 69.1% (95% CI 66.2% to 71.9%). CONCLUSIONS: There is substantial potential for presymptomatic transmission of SARS-CoV-2 across a range of different contexts. This highlights the need for rapid case detection, contact tracing and quarantine. The transmission patterns that we report reflect the combination of biological infectiousness and transmission opportunities which vary according to context. BMJ Publishing Group 2021-06-28 /pmc/articles/PMC8245290/ /pubmed/34183334 http://dx.doi.org/10.1136/bmjopen-2020-041240 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Epidemiology Casey-Bryars, Miriam Griffin, John McAloon, Conor Byrne, Andrew Madden, Jamie Mc Evoy, David Collins, Áine Hunt, Kevin Barber, Ann Butler, Francis Lane, Elizabeth Ann O'Brien, Kirsty Wall, Patrick Walsh, Kieran More, Simon John Presymptomatic transmission of SARS-CoV-2 infection: a secondary analysis using published data |
title | Presymptomatic transmission of SARS-CoV-2 infection: a secondary analysis using published data |
title_full | Presymptomatic transmission of SARS-CoV-2 infection: a secondary analysis using published data |
title_fullStr | Presymptomatic transmission of SARS-CoV-2 infection: a secondary analysis using published data |
title_full_unstemmed | Presymptomatic transmission of SARS-CoV-2 infection: a secondary analysis using published data |
title_short | Presymptomatic transmission of SARS-CoV-2 infection: a secondary analysis using published data |
title_sort | presymptomatic transmission of sars-cov-2 infection: a secondary analysis using published data |
topic | Epidemiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245290/ https://www.ncbi.nlm.nih.gov/pubmed/34183334 http://dx.doi.org/10.1136/bmjopen-2020-041240 |
work_keys_str_mv | AT caseybryarsmiriam presymptomatictransmissionofsarscov2infectionasecondaryanalysisusingpublisheddata AT griffinjohn presymptomatictransmissionofsarscov2infectionasecondaryanalysisusingpublisheddata AT mcaloonconor presymptomatictransmissionofsarscov2infectionasecondaryanalysisusingpublisheddata AT byrneandrew presymptomatictransmissionofsarscov2infectionasecondaryanalysisusingpublisheddata AT maddenjamie presymptomatictransmissionofsarscov2infectionasecondaryanalysisusingpublisheddata AT mcevoydavid presymptomatictransmissionofsarscov2infectionasecondaryanalysisusingpublisheddata AT collinsaine presymptomatictransmissionofsarscov2infectionasecondaryanalysisusingpublisheddata AT huntkevin presymptomatictransmissionofsarscov2infectionasecondaryanalysisusingpublisheddata AT barberann presymptomatictransmissionofsarscov2infectionasecondaryanalysisusingpublisheddata AT butlerfrancis presymptomatictransmissionofsarscov2infectionasecondaryanalysisusingpublisheddata AT laneelizabethann presymptomatictransmissionofsarscov2infectionasecondaryanalysisusingpublisheddata AT obrienkirsty presymptomatictransmissionofsarscov2infectionasecondaryanalysisusingpublisheddata AT wallpatrick presymptomatictransmissionofsarscov2infectionasecondaryanalysisusingpublisheddata AT walshkieran presymptomatictransmissionofsarscov2infectionasecondaryanalysisusingpublisheddata AT moresimonjohn presymptomatictransmissionofsarscov2infectionasecondaryanalysisusingpublisheddata |